CYTOKINETICS INC
CYTK
92 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Apr 7 8:26 PM | FADY MALIK | Proposed Sale | 22,000 | $64.94 | $1.4M | — | View → |
| Apr 1, 2026 | Apr 1 8:47 PM | ROBERT BLUM | Proposed Sale | 45,000 | $65.91 | $3.0M | — | View → |
| Apr 1, 2026 | Apr 1 8:34 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $66.63 | $499.7K | 422,830(D) | View → |
| Mar 31, 2026 | Mar 31 8:24 PM | ANDREW CALLOS | Proposed Sale | 3,639 | $62.97 | $229.1K | — | View → |
| Mar 31, 2026 | Mar 31 8:21 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 3,639 | $65.00 | $236.5K | 66,004(D) | View → |
| Mar 17, 2026 | Mar 18 9:46 PM | Sung LeeEVP, Chief Financial Officer | Sale | 4,935 | $62.15 | $306.7K | 87,127(D) | View → |
| Mar 17, 2026 | Mar 18 9:43 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 8,542 | $62.15 | $530.9K | 71,573(D) | View → |
| Mar 17, 2026 | Mar 18 9:40 PM | Fady Ibraham MalikEVP Research & Development | Sale | 12,033 | $62.15 | $747.9K | 153,902(D) | View → |
| Mar 17, 2026 | Mar 18 9:37 PM | Robert I BlumDirector, President & CEO | Sale | 36,601 | $62.15 | $2.3M | 430,330(D) | View → |
| Mar 18, 2026 | Mar 18 8:55 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 1,930 | $62.07 | $119.8K | 78,185(D) | View → |
| Mar 18, 2026 | Mar 18 8:31 PM | ANDREW CALLOS | Proposed Sale | 1,930 | $62.13 | $119.9K | — | View → |
| Mar 16, 2026 | Mar 16 9:14 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 1,709 | $61.03 | $104.3K | 46,149(D) | View → |
| Mar 16, 2026 | Mar 16 8:39 PM | ANDREW CALLOS | Proposed Sale | 1,709 | $60.06 | $102.6K | — | View → |
| Mar 9, 2026 | Mar 10 10:05 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 2,582 | $60.72 | $156.8K | 47,858(D) | View → |
| Mar 9, 2026 | Mar 10 10:03 PM | Fady Ibraham MalikEVP Research & Development | Sale | 2,907 | $60.72 | $176.5K | 138,629(D) | View → |
| Mar 9, 2026 | Mar 10 10:00 PM | Robert I BlumDirector, President & CEO | Sale | 7,931 | $60.72 | $481.6K | 391,673(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 26,000 | $61.87 | $1.6M | 50,440(D) | View → |
| Mar 2, 2026 | Mar 2 9:37 PM | B LYNNE PARSHALL | Proposed Sale | 10,000 | $62.22 | $622.2K | — | View → |
| Mar 2, 2026 | Mar 2 9:29 PM | Lynne B ParshallDirector | Sale | 5,000 | $61.21 | $306.1K | 17,933(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 886 | $61.62 | $54.6K | 50,440(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:11 PM | Robert I BlumDirector, President & CEO | Grant/Award | 113,529 | $60.06 | 111,864(D) | View → |
| Mar 15, 2026 | Mar 17 8:08 PM | Andrew CallosEVP, Chief Commercial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:06 PM | Jeffrey HessekielChief Legal & Admin Officer | Grant/Award | 31,145 | $60.06 | 22,820(D) | View → |
| Mar 15, 2026 | Mar 17 8:05 PM | Sung LeeEVP, Chief Financial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:03 PM | Fady Ibraham MalikEVP Research & Development | Grant/Award | 41,192 | $60.06 | 39,527(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 26,000 | $39.13 | 69,000(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 1:17 AM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 84,000(D) | View → |
| Feb 2, 2026 | Feb 2 9:40 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 886(D) | View → |
← Previous
Page 3 of 3